Loading...
XTAI
4164
Market cap306mUSD
Jun 13, Last price  
49.00TWD
1D
-1.61%
1Q
-2.00%
Jan 2017
11.87%
IPO
-65.66%
Name

CHC Healthcare Group

Chart & Performance

D1W1MN
XTAI:4164 chart
No data to show
P/E
53.73
P/S
2.51
EPS
0.91
Div Yield, %
4.09%
Shrs. gr., 5y
1.79%
Rev. gr., 5y
4.07%
Revenues
3.60b
-7.13%
170,398,0001,867,510,0001,995,368,0001,989,670,0002,062,991,0002,091,026,0002,395,331,0002,205,206,0002,117,116,0002,507,466,0002,950,052,0002,554,911,0002,439,564,0002,974,352,0003,877,137,0003,600,574,000
Net income
168m
-59.80%
6,299,000483,548,000583,450,000430,685,000296,862,000265,766,000226,518,000158,932,000-86,695,000323,422,000395,172,000366,389,000381,633,000356,571,000418,866,000168,384,000
CFO
99m
-89.68%
-61,917,000510,142,000477,215,000295,942,000869,311,000634,233,000504,900,0001,137,168,000293,816,000390,688,0001,189,693,000915,465,000692,795,000656,659,000962,588,00099,367,000
Dividend
Jul 10, 20242.00487 TWD/sh
Earnings
Aug 05, 2025

Profile

CHC Healthcare Group, together with its subsidiaries, provides a range of healthcare management services in Taiwan and internationally. It sells, installs, maintains, leases, and distributes medical equipment. The company is also involved in the provision of business management consultation and education training; elderly care business; and radiation sterilization business. In addition, it offers a range of equipment in the areas of radiation oncology, neurology, medical imaging, ophthalmology, and surgery. The company was founded in 1977 and is headquartered in Taipei, Taiwan.
URL
http://www.chcg.com/
IPO date
Oct 18, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,600,574
-7.13%
3,877,137
30.35%
2,974,352
21.92%
Cost of revenue
3,363,906
3,263,384
2,494,435
Unusual Expense (Income)
NOPBT
236,668
613,753
479,917
NOPBT Margin
6.57%
15.83%
16.14%
Operating Taxes
40,430
134,192
95,185
Tax Rate
17.08%
21.86%
19.83%
NOPAT
196,238
479,561
384,732
Net income
168,384
-59.80%
418,866
17.47%
356,571
-6.57%
Dividends
(349,055)
(324,722)
(323,879)
Dividend yield
4.50%
2.75%
3.88%
Proceeds from repurchase of equity
776
18,368
14,361
BB yield
-0.01%
-0.16%
-0.17%
Debt
Debt current
2,601,422
616,469
454,639
Long-term debt
3,456,355
4,832,811
4,766,398
Deferred revenue
672,241
657,915
645,381
Other long-term liabilities
128,023
63,180
55,270
Net debt
4,046,801
3,309,600
3,445,706
Cash flow
Cash from operating activities
99,367
962,588
656,659
CAPEX
(431,086)
(582,944)
(682,633)
Cash from investing activities
(544,855)
(500,465)
(339,979)
Cash from financing activities
188,238
(42,048)
(346,452)
FCF
(327,334)
300,732
(211,108)
Balance
Cash
1,725,164
2,026,850
1,719,904
Long term investments
285,812
112,830
55,427
Excess cash
1,830,947
1,945,823
1,626,613
Stockholders' equity
2,479,805
2,629,566
2,926,369
Invested Capital
11,383,506
10,758,836
10,433,222
ROIC
1.77%
4.53%
3.73%
ROCE
1.78%
4.79%
3.95%
EV
Common stock shares outstanding
185,662
193,571
191,812
Price
41.80
-31.59%
61.10
40.30%
43.55
14.45%
Market cap
7,760,672
-34.38%
11,827,188
41.59%
8,353,413
18.24%
EV
12,176,686
15,453,879
12,060,599
EBITDA
870,635
1,208,216
979,299
EV/EBITDA
13.99
12.79
12.32
Interest
98,352
89,001
71,267
Interest/NOPBT
41.56%
14.50%
14.85%